18 completed, 8 unknown, 6 recruiting, 1 active not recruiting. 13 Not applicable, 7 Phase 4, 4 Phase 2, 4 Phase 3.
Follow H. Pylori Infection: new trials by email Literature Review of H. Pylori Infection trials Research Report on H. Pylori Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| H. Pylori Eradication With Argon Plasma During Endoscopy HEAPE, Pre-HEAPE - Helicobacter Pylori Infection, Helicobacter Pylori | Not applicable | Recruiting | Christopher C. Thompson, MD, MSc | 20 | 2025-07-08 | 2026-03-02 |
| Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection Bismuth quadruple therapy, Saccharomyces boulardii - H. Pylori Infection | Not applicable | Not yet recruiting | Zhongda Hospital | 208 | 2025-06-01 | 2025-06-10 |
| Recurrence of H Pylori : Incidence and Influential Factors. follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence - H. Pylori Infection | Not applicable | Recruiting | Sohag University | 100 | 2025-05-13 | 2025-07-01 |
| Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection, Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection, Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection - H. Pylori Infection | Not applicable | Recruiting | Sohag University | 150 | 2025-05-13 | 2025-07-01 |
| Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 PYTEST® 14C-Urea Capsule Breath Test (at Home), PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) - H. Pylori Infection, Gastric Cancer | Phase 4 | Completed | University of Miami | 50 | 2024-11-06 | 2026-10-16 |
| Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori Keverprazan, Amoxicillin - H. Pylori Infection | Phase 4 | Unknown | Nanjing First Hospital, Nanjing Medical University | 268 | 2024-06-01 | 2024-05-14 |
| Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis. probiotic - H. Pylori Infection, Carcinogenesis | Not applicable | Active not recruiting | National Cheng-Kung University Hospital | 100 | 2024-03-20 | 2024-11-14 |
| The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21 Meiji Yogurt Group - H. Pylori Infection | Not applicable | Completed | Meiji China Investment Co.,Ltd | 140 | 2023-09-26 | 2026-02-13 |
| Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection H. Pylori Infection | Completed | Hamdard University | 69 | 2023-08-15 | 2024-03-13 | |
| Oral Helicobacter Pylori Eradication MAXPOWER Biological Antibacterial Liquid, Water - H. Pylori Infection | Not applicable | Unknown | Changhai Hospital | 42 | 2023-03-01 | 2023-09-21 |
| TLR 9 (rs352140) Gene Polymorphism in Helicobacter Pylori Infection TLR TLR 9 (rs352140) gene polymorphism - H. Pylori Infection | Not applicable | Completed | Benha University | 100 | 2023-01-01 | 2025-12-17 |
| A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection Comparing Load and Concomitant therapy - H. Pylori Infection | Phase 4 | Completed | Helwan University | 200 | 2022-07-21 | 2023-09-26 |
| Screening Strategy for Gastric Cancer Prevention UBT, HPSA, UBT and HPSA - H. Pylori Infection | Not applicable | Recruiting | National Taiwan University Hospital | 4403 | 2022-07-19 | 2025-08-17 |
| Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection (A) T-V14, (B) T-V7, (C) D-V14 - H. Pylori Infection | Phase 4 | Recruiting | National Taiwan University Hospital | 1200 | 2021-03-10 | 2023-03-08 |
| Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection esomeprazole plus amoxicillin, amoxicillin, furazolidone, bismuth potassium citrate , esomeprazole - H. Pylori Infection | Not applicable | Unknown | Shanghai Zhongshan Hospital | 186 | 2021-01-01 | 2022-08-05 |
| Bismuth for PCAB-based H. Pylori Eradication H. pylori eradication - H. Pylori Infection | Completed | Soonchunhyang University Hospital | 150 | 2020-03-01 | 2023-11-22 | |
| Patient-Centered Cancer Prevention In Chinese Americans Test-and-treat EHR-CHW intervention, Usual care of EHR-only intervention - H. Pylori Infection | Not applicable | Completed | NYU Langone Health | 135 | 2018-08-15 | 2024-07-03 |
| H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy H. pylori eradication - H. Pylori Infection | Completed | Soonchunhyang University Hospital | 270 | 2018-01-01 | 2022-02-24 | |
| Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01) Neoplasm, Stomach, H. Pylori Infection | Unknown | Jian-Kun Hu | 30000 | 2017-01-01 | 2018-07-24 | |
| Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori Eradication of H. pylori - H. Pylori Infection | Phase 2 | Unknown | Hamamatsu University | 100 | 2016-05-01 | 2016-05-04 |
Showing 20 of 35. Sign in to see all of them.
Stomach Neoplasms (2) · Carcinogenesis (1) · Disease (1) · Dyspepsia (1) · Gastritis (1) · Gastritis, Atrophic (1) · Stomach Ulcer (1)
Digestive System Diseases (4) · Gastrointestinal Diseases (4) · Stomach Diseases (4) · Neoplasms (3) · Pathological Conditions, Signs and Symptoms (3) · Digestive System Neoplasms (2) · Gastroenteritis (2) · Gastrointestinal Neoplasms (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Duodenal Diseases (1) · Gastritis (1) · Intestinal Diseases (1) · Neoplastic Processes (1) · Peptic Ulcer (1)
Amoxicillin (5) · Clarithromycin (3) · Esomeprazole (3) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · Acetazolamide (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Anti-Bacterial Agents (1) · BID protein, human (1) · Cholecalciferol (1) · Fumigant 93 (1) · Furazolidone (1) · Hydrotherapy (1) · Lansoprazole (1) · Metronidazole (1) · Omeprazole (1)
National Taiwan University Hospital (5) · Hamamatsu University (3) · Sohag University (2) · Soonchunhyang University Hospital (2) · ARJ Medical, Inc. (1) · Benha University (1) · Changhai Hospital (1) · Chinese University of Hong Kong (1) · Christopher C. Thompson, MD, MSc (1) · Hamdard University (1) · Helwan University (1) · Javier P. Gisbert (1) · Jian-Kun Hu (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Lama Medical Care s.r.o. (1)
China (6) · Taiwan (6) · United States (5) · Egypt (4) · Japan (4) · South Korea (4) · Germany (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Croatia (1) · Czechia (1) · Denmark (1) · Estonia (1) · Finland (1)
Jun-Hyung Cho, M.D. (2) · Jyh-Ming Liou, MD (2) · Christopher C Thompson, MD (1) · Helmut Neumann, M.D., Ph.D. (1) · Justin CY Wu, MBChB(CUHK) (1) · Jyh-Chin Yang, M.D. (1) · Jyh-Ming Liou, M.D (1) · Ladislav Kuzela, MD (1) · Markus F. Neurath, M.D., Ph.D. (1) · Naohito Shirai, MD., PhD. (1) · Nayoung Kim, M.D (1) · Shria Kumar, MD (1) · Simona Kwon, DrPH,MPH (1)
PMID 23158886, PMID 26142048, PMID 26935876, PMID 30978536, PMID 33176617, PMID 33840725, PMID 34883037, PMID 34948194, PMID 34954341, PMID 36591610, PMID 36830102, PMID 37760736, PMID 37983769, PMID 38459869, PMID 38811871, PMID 39001621, PMID 39461739, PMID 39495800, PMID 39902822, PMID 40167351, PMID 40178062, PMID 40462044, PMID 41168889, PMID 41656747, PMID 41923280, PMID 41935593
U54MD000538 (1)